Mark Bodenrader

Insider Reports History

Location
Boston, MA
Signature
/s/ Mark Bodenrader
All insider transactions
Transactions in reports broken out by “transaction date” reported in original SEC filing, see here for transactions aggregated across transaction date

Holdings reported by Mark Bodenrader:

Company Role Class Num Shares Value Price $ Report Date Ownership
Cerevel Therapeutics Holdings, Inc. Senior Vice President, Finance and Chief Accounting Officer Common Stock 0 $0 $41.18 01 Aug 2024 Direct
Cerevel Therapeutics Holdings, Inc. Senior Vice President, Finance and Chief Accounting Officer Restricted Stock Units 0 $0 $41.18 01 Aug 2024 Direct
Cerevel Therapeutics Holdings, Inc. Senior Vice President, Finance and Chief Accounting Officer Stock Option (Right to Buy) 0 01 Aug 2024 Direct

Insider Reports Filed by Mark Bodenrader

Symbol Company Period Transactions Value $ Form Type Role Filing Time
/report/000095017024090801-bodenrader-mark-2024-08-01 Cerevel Therapeutics Holdings, Inc. 01 Aug 2024 3 $0 4 Senior Vice President, Finance and Chief Accounting Officer 05 Aug 2024, 16:24
/report/000095017024006678-bodenrader-mark-2024-01-19 Cerevel Therapeutics Holdings, Inc. 19 Jan 2024 1 $0 4 Title: Senior Vice President, Finance and Chief Accounting Officer 23 Jan 2024, 17:37
/report/000095017023072381-bodenrader-mark-2023-12-19 Cerevel Therapeutics Holdings, Inc. 19 Dec 2023 5 -$326,788 4 Title: Senior Vice President, Finance and Chief Accounting Officer 21 Dec 2023, 20:27
/report/000095017023026500-bodenrader-mark-2023-06-01 Cerevel Therapeutics Holdings, Inc. 01 Jun 2023 3 -$62,440 4 Title: Senior Vice President, Finance and Chief Accounting Officer 05 Jun 2023, 20:07
/report/000089924323004358-bodenrader-mark-2023-02-06 Cerevel Therapeutics Holdings, Inc. 06 Feb 2023 2 $0 4 Officer 08 Feb 2023, 19:26
/report/000089924322020994-bodenrader-mark-2022-06-01 Cerevel Therapeutics Holdings, Inc. 01 Jun 2022 1 $0 4 Title: Interim Chief Financial Officer, Vice President, Finance and Chief Accounting Officer 03 Jun 2022, 16:45
/report/000089924322005942-bodenrader-mark-2022-02-09 Cerevel Therapeutics Holdings, Inc. 09 Feb 2022 1 $0 4 Title: Interim Chief Financial Officer, Vice President, Finance and Chief Accounting Officer 11 Feb 2022, 17:47